A natural binder for binding biomasses and industrial waste and/or recycled materials, using processes employed for petroleum-derived binders, includes a mixture of a protein flour, a plant hydrolyzate, and a magnesium oxide.

A natural binder for binding biomasses and industrial waste and/or recycled materials, using processes employed for petroleum-derived binders, includes a mixture of a protein flour, a plant hydrolyzate, and a magnesium oxide.

The present invention relates to a process of converting feather materials into keratin-rich microfibers and soluble protein hydrolysate, the process comprising using a microbial hydrolysis technique.

The disclosure herein relates to photoinitiated dermal fillers, hyaluronic acid-rhCollagen double crosslinked dermal fillers and hyaluronic acid-rhCollagen semi interpenetrated network, each comprising plant-derived human collagen, as well as methods of using the same.

The disclosure herein relates to photoinitiated dermal fillers, hyaluronic acid-rhCollagen double crosslinked dermal fillers and hyaluronic acid-rhCollagen semi interpenetrated network, each comprising plant-derived human collagen, as well as methods of using the same.

One aspect of the invention provides a method of treating a chronic wound including administering to the wound at least one agent from a delivery system wherein the agent induces sequential conversion of a first population of wound macrophages in the wound to M2A macrophages and a second population of wound macrophages to M2C macrophages. The sequential conversion of the wound macrophages promotes tissue remodeling.

One aspect of the invention provides a method of treating a chronic wound including administering to the wound at least one agent from a delivery system wherein the agent induces sequential conversion of a first population of wound macrophages in the wound to M2A macrophages and a second population of wound macrophages to M2C macrophages. The sequential conversion of the wound macrophages promotes tissue remodeling.

The present invention relates to silk fibroin bioinks specifically formulated for use in 3D bioprinting and the production of ex-vivo models capable of supporting hematopoiesis and the production of platelets and blood cells.

The present invention relates to silk fibroin bioinks specifically formulated for use in 3D bioprinting and the production of ex-vivo models capable of supporting hematopoiesis and the production of platelets and blood cells.

A method of treating a biobased feedstock derived from agricultural resources and specifically from the non-distillate products of fermentation-derived renewable fuel and distilled spirit processes. The separation of thermally labile components from biobased feedstocks result in materials that are thermally stable and better suited for subsequent melt processing in a polymer matrix.